A US company called Honu Xpress says that it has acquired a license for the Mystabis cannabis MDI which it claims “provides pressurized metered-doses of cannabis oil directly to the lung’s capillaries with little to no exhale” and up to 95% bioavailabilty. The company said that it plans to sell the inhaler in US and foreign markets except for Canada and Australia “after funding the transaction and meeting other customary terms.”
The Mystabis web site says that all of the inhaler components are pharmaceutical grade and advises that using a spacer with a face mask and “inhaling the aerosol through the nose is particularly satisfying.”
Honu Xpress says, “Without the use of any form of heat or combustion, this pressurized inhaler (“pMDI”) delivers exact quantities of aerosolized cannabinoids in a manner that provides rapid medicinal effects while preserving the entourage effects of the cannabinoids and terpenoids, unlike distillate inhalers,” adding that “Physicians will find the delivery mechanism to be very familiar and will appreciate the precision, controlled dosage delivery of both the THC and other licensed cannabinoid formulations (THC with THC-V, CBD, CBG, CBN, etc., to name a few promising favorites).”
Honu Xpress CEO Mike Arnold, commented, “It has been thirteen months since I discovered the inhaler technology on Google’s patent search. It’s an amazing technology. It’s effectively a pocket ‘dab hit.’ The Dab Puff Inhaler has the potential of changing the way cannabis is consumed and overindulged. New users will now be able to experience cannabis with a controlled and predictable dosage in a fast-acting way (estimated five- to 45-second activation time).”
He adds, “The beauty of this tech is that it is essentially an aerosolized dab hit where the non-vaporized particles are just small enough to clear the throat and enter the lungs but too big to be exhaled. We already have meetings with potential licensees, including one publicly traded company, and find this particular device to be in high demand, given it’s the only inhaler out there that uses whole-plant extract and waxes. Also, the inhaler has proof of concept already in California and Oregon under former licensing agreements. It’s an amazing discreet way to experience the potential entourage effect in a way that is totally controlled by the end user.”
Read the Honu Xpress press release.
